HomeInsightsMarket Capitalization

Market Capitalization of Themis Medicare Ltd

Market Capitalization of Themis Medicare Ltd

stocks purchased

₹ 1.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

37.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Themis Medicare Ltd

NSE: THEMISMED

Market Cap

₹ 2664.56 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Themis Medicare Ltd is ₹ 2664 crore as of 22 Nov 24 .
  • The Market Cap of Themis Medicare Ltd changed from ₹ 272.17 crore on March 2019 to ₹ 2015 crore on March 2024 . This represents a CAGR of 39.61% over 6 years.
  • The Latest Trading Price of Themis Medicare Ltd is ₹ 289.5 as of 22 Nov 15:30 .
  • The dividend payouts of Themis Medicare Ltd changed from ₹ 1.75 to ₹ 0.5 over 5 quarters. This represents a CAGR of -63.29% .

Historical Market Cap of Themis Medicare Ltd

No data available

* All values are in crore

Company Fundamentals for Themis Medicare Ltd

No data available

Image

Themis Medicare Ltd

NSE: THEMISMED

Share Price

₹ 289.5

1.90 (0.66%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Themis Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Themis Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024289.5
21 Nov 2024287.6
19 Nov 2024286.4
18 Nov 2024286.2
14 Nov 2024272.4
13 Nov 2024262.95
12 Nov 2024275.8
11 Nov 2024275.35
08 Nov 2024275.8
07 Nov 2024277.85

SWOT Analysis Of Themis Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Themis Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Themis Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Themis Medicare Ltd

No data available

No data available

Historical P/E Ratio of Themis Medicare Ltd

No data available

* All values are in %

Historical Revenue of Themis Medicare Ltd

No data available

* All values are in crore

Historical EBITDA of Themis Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Themis Medicare Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Themis Medicare Ltd

No data available

* All values are in

About Themis Medicare Ltd

  • Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
  • The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
  • Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
  • The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

Themis Medicare Ltd News Hub

News

Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October...

Read more

19 Oct 202410:22

News

Themis Medicare to hold board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 20...

Read more

17 Jul 202409:49

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

15 May 202410:44

News

Themis Medicare schedules AGM

Themis Medicare announced that the 54th Annual General Meeting(AGM) of the company will be...

Read more

15 May 202410:44

News

Themis Medicare announces board meeting date

Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 May 202...

Read more

04 May 202410:14

News

Themis Medicare announces board meeting date

Themis Medicare will hold a meeting of the Board of Directors of the Company on 10 Februar...

Read more

30 Jan 202415:36

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Themis Medicare Ltd Market Cap

What is the market cap of Themis Medicare Ltd?

As of November 24, 2024, Themis Medicare Ltd has a market capitalization of ₹2664.56, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Themis Medicare Ltd's market capitalization?

Themis Medicare Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Themis Medicare Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Themis Medicare Ltd's market capitalization change?

Themis Medicare Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*